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Abstract 
Objective: Human amniotic epithelial cells (hAECs) are a novel source of stem cells and have immunomodulatory 
effects on both the innate and adoptive immune system. hAECs can differentiate into multiple cell lineages that 
make them a suitable cell source for regenerative medicine. These cells express multiple toll-like receptors (TLRs) and 
respond to various TLR ligands. This study aimed to evaluate the effect of lipopolysaccharide (LPS), a TLR4 ligand, on 
the level of immunomodulatory and immunostimulatory factors of hAECs.
Results: Our results indicated that LPS had the ability to up-regulate the expression of prostaglandin E2 synthase and 
transforming growth factor-beta1 in hAECs. However, there was no change in the level of interleukin-1beta, interleu-
kin-6 and interleukin-10 in hAECs when were stimulated with LPS. In addition, we observed tumor necrosis factor-
alpha was only expressed at very low level in some of hAECs samples which its expression was independent of the 
effects of LPS.
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Introduction
The amnion membrane is the innermost layer of the fetal 
membranes and consists of epithelial cells and avascu-
lar stroma [1]. Human amniotic epithelial cells (hAECs) 
have unique properties that distinguish them from other 
human cell sources. hAECs express HLA-G which is an 
inhibitory ligand for B and T lymphocytes, natural killer 
(NK), and dendritic cells [2, 3] These cells have the ability 
to modulate immune responses through the secretion of 
soluble molecules and cell–cell contact [3]. hAECs utilize 
various immunosuppressive molecules such as TGF- β1, 
prostaglandin E2 (PGE2), and Fas ligand (Fas L) [4, 5]. 
These immunosuppressive agents play a crucial role in 
regulating immune response and preventing the develop-
ment of autoimmune disorders through the inhibition of 
T cell proliferation, the shift of immune responses toward 
Th2-type responses and the reduction of pro-inflamma-
tory responses [4].
In addition to immunomodulatory activities, these cells 
are proposed as a novel source of stem cells that differ-
entiate into different cell types originating from three 
germ layers without any of the ethical concerns related to 
human stem cells [6]. hAECs express some of the func-
tional toll-like receptors (TLRs) such as TLR2/TLR6, 
TLR4, and TLR5, which are important regulators of the 
innate immune system and recognize pathogens by con-
served pathogen associated molecular patterns (PAMPs) 
[7]. TLR2/TLR6 and TLR5 stimulation on hAECs induce 
the production of IL-8 and IL-6 [7]. Previous studies 
indicated that the human placenta responds to different 
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PAMPs by TLRs expression [8]. Activation of TLRs by 
PAMPs triggers intracellular signaling cascades resulting 
in the activation of nuclear factor-kappa B (NF-κB) and 
activation protein-1(AP-1), which are known as key tran-
scription factors responsible for the expression of pro-
inflammatory cytokines including IL-1, IL-6 and TNF-α. 
Pro-inflammatory cytokines stimulate the production of 
prostaglandins in the fetal membranes, thereby causing 
uterine contractions [7]. Therefore, engagement of TLRs 
by PAMP and, subsequently, the production of different 
factors of hAECs suggest that the fetal membranes play a 
pivotal role in the immune system.
Regarding the fact that the immunosuppressive and 
immunostimulatory effects of hAECs are mainly medi-
ated by soluble molecules such as TGF-β1, PGE2, TNF-α 
and IL-6 [3–5], this study aimed to examine the effect 
of lipopolysaccharides (LPS), a ligand for TLR4, on the 
expression of soluble factors of hAECs such as TGF-β1, 
PGE2, IL-10, IL-1β, TNF-α and IL-6, which mediate the 
immunomodulatory and immunostimulatory effects of 
these cells.
Main text
Methods
hAECs isolation
Term placentas were obtained from 10 healthy pregnant 
women during uncomplicated elective cesarean deliver-
ies. hAECs were isolated using a method described pre-
viously [9]. Briefly, the amnion membrane was manually 
peeled off from the chorion and washed several times 
with phosphate buffered saline (PBS). The amnion was 
then digested at 37  °C for 10  min with 0.05% EDTA/
trypsin (Gibco, USA). The digestion of the amnion layer 
was followed twice at 37 °C for 30 min with 0.05% EDTA/
trypsin. The isolated cells from the second and third 
digests were pooled and washed with ice-cold RPMI 
medium.
Assessment of the purity of hAECs by flow cytometry
To determine the purity of hAECs isolated from five 
amnion membranes, the cells (8 × 105) were stained with 
FITC anti-human CD105, FITC anti-human CD90, and 
matched-isotype control IgG antibodies, as negative con-
trols, at 4 °C for 25 min (Additional file 1: Table S1). Mes-
enchymal stem cells (MSCs) were used as positive control 
for anti-CD90 and anti-CD105 antibodies. Next, fixation 
and permeabilization of the cells were preformed for 
intracellular staining with Alexa  Fluor® 488 anti-human 
cytokeratin or matched-isotype control IgG antibodies 
(Additional file  1: Table  S1) according to the manufac-
turere’s protocol (eBioscience, USA). The cells were then 
washed three times with cell staining buffer (Biolegend, 
USA) and the purity of the cells was analyzed using a 
FACSCalibur flow cytometer (Becton–Dickinson, CA).
hAECs culture
hAECs obtained from ten healthy pregnant women 
were cultured in 25 cm2 tissue culture flasks at a density 
of 2.5 × 105  cells/cm2 in DMEM/F12 medium (Gibco, 
USA) supplemented with 10% FBS (Gibco, USA) and 
1% penicillin/streptomycin (Sigma-Alderich, USA). LPS 
(1 mg, Sigma-Alderich, USA) was dissolved in 1 ml RPMI 
medium to yield a stock concentration of 1 mg/ml. After 
24 h of incubation at 37 °C, one set of the cultured hAECs 
were stimulated with LPS (5  µg/ml) and incubated at 
37 °C with 5%  CO2. All assays were performed in dupli-
cate and randomization was used while performing the 
experiment. After 6  h, adhered hAECs which were cul-
tured in the presence or absence of LPS were dissoci-
ated by trypsin and washed twice with PBS for total RNA 
extraction.
RNA extraction, reverse transcription and quantitative 
polymerase chain reaction (qPCR)
For gene expression analysis, total RNAs from ten hAEC 
samples which were cultured in the presence or absence 
of LPS were extracted using the RNeasy Mini RNA iso-
lation kit according to the manufacturer’s protocol (Qia-
gen, USA). The investigators were blinded to sample 
information. RNA yield was determined and the purity 
was assessed using a spectrophotometer (NanoDrop 
8000 spectrophotometer, Thermo scientific, USA). Com-
plementary deoxyribonucleic acid (cDNA) synthesis was 
done using RevertAid First Strand cDNA Synthesis Kit 
(Thermo scientific, USA) following the manufacturer’s 
instructions. q PCR assay was done using an ABI7700 
machine (Applied Biosystems, Foster City, USA) and the 
 SYBR® Premix Ex Taq™ II Master Mix (Takara, Japan) 
according to the manufacturer’s instructions. Each reac-
tion was initiated at 95 °C for 15 s, followed by 45 cycles 
of 95 °C for 5 s and 58 °C for 40 s. All analyses were per-
formed in triplicate. Threshold cycles (Ct) and melting 
curves were generated automatically by the Applied Bio-
systems software. The expression levels of each sample 
were normalized to glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) as an endogenous control. The 
cycling parameters for GAPDH were similar to those 
used for the cytokines. The Relative Expression Soft-
ware Tool 2009 (REST 2009) [10] was used to calculate 
the relative expression of the target genes, using the ratio 
of the Ct values and the PCR amplification efficiencies 
of the target genes and the GAPDH gene. REST 2009 
uses randomization and bootstrapping methods to test 
the statistical significance of the gene expression ratios 
and calculate 95% confidence intervals for relative fold 
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changes [11]. Primer sequences are shown in Additional 
file 1: Table S2.
Statistical analysis
The results are expressed as mean ± standard error (SE) 
and mean ± standard error of mean (SEM). REST 2009 
was used for group-wise comparison and statistical 
analysis of relative expression results in real-time PCR. 
p < 0.05 was considered statistically significant.
Results
The purity of hAECs
To assess the purity of hAEC, the percentage of cells 
which were positive for cytokeratin, CD90 and CD105 
was measured by flow cytometry. Our results revealed 
that more than 97% of the isolated cells expressed 
cytokeratin and less than 1% of the cells were positive for 
CD90 and CD105 (Fig. 1a–c).
LPS effects on expression of immunosuppressive factors 
in hAECs
Since immunomodulatory effects of hAECs make them 
as a cell source for cellular therapy, LPS effects on expres-
sion of immunosuppressive mediators in hAECs was 
evaluated. Our data showed a significant increase in the 
expression level of PGE2 synthase, an enzyme which pro-
duces PGE2, and TGF-β1 in the sample group (hAECs 
treated with LPS) compared to the control group (hAECs 
cultured in the absence of LPS) (Fig.  2, p < 0.001–0.05). 
Although there was a numerical increase in the mean 
of IL-10 expression level in the sample group compared 
to the control group, LPS could not induce the IL-10 
expression in the sample group (Fig. 2).
LPS effects on induction of pro‑inflammatory cytokines 
in hAECs
Regarding pro-inflammatory cytokines play an impor-
tant role in the induction of immune response against the 
cells used with therapeutic purposes, we evaluated LPS 
effect on the expression of pro-inflammatory cytokines in 
hAECs. In spite of a numerical decrease in IL-6 level and 
Fig. 1 The purity of isolated hAECs isolated from the amnion membrane. a More than 97% of the isolated hAECs were positive for cytokeratin, an 
epithelial cell marker. b, c < 1% of the isolated cells were positive for MSC markers [CD90 (b) and CD105 (c)]. Blue shaded histogram: MSCs were 
stained with anti-CD90 (b) and anti-CD105 (c) antibodies as positive controls. Gray shaded histogram: hAECs were stained with matched-isotype 
control antibodies as negative controls (a–c). Black line: hAECs were stained with anti-cytokeratin (a), anti-CD90 (b) and anti-CD105 (c) antibodies. 
Data are representative of five independent experiments. All data show mean ± SEM
Fig. 2 The expression level of immunosuppressive agents in hAECs. 
hAECs were cultured in the presence or absence of LPS for 6 h. 
The effects of LPS on the expression of PGE2 synthase, TGF-β1 and 
IL-10 in hAECs were evaluated by real-time PCR assay. All data are 
shown as mean ± SE. The depicted results are representative of ten 
independent experiments. Asterisk indicates that the difference in 
the expression levels are statistically significant. NS indicates that 
the difference in the expression levels is not statistically significant. 
*p < 0.05, ***p < 0.001
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an increase in IL-1β level in the sample group, the results 
of the study indicated that LPS did not influence the 
expression of IL-6 and IL-1β in hAECs (Fig. 3). Moreover, 
we found that TNF-α was expressed at very low level in 
hAECs and was only detectable in some samples such as 
sample 6, 7 and 10.
Discussion
Immune-rejection and tumorigenic upon transplanta-
tion are two major problems which challenge the use of 
cell therapy for the treatment of different diseases [12, 
13]. To date, multiple cell sources have been employed in 
regenerative medicine and the treatment of diseases with 
immune pathophysiology, but these treatments have not 
been uniformly successful and the evidence is insufficient 
to support the efficacy of these therapeutic approaches 
[12]. hAECs which are stem cells with the immunomodu-
latory effects may be considered as a potential candidate 
in the regenerative medicine and immunotherapy for 
inflammatory diseases. In addition, some unique charac-
teristics of these cells make them an interesting source of 
cells for use as therapy in regenerative medicine. These 
cells express very low level of human leukocyte antigens 
(HLA) class I and are negative for HLA-class II and co-
stimulatory molecules, which may potentially reduce the 
risk of immune-rejection after clinical applications [14]. 
hAECs do not express telomerase and thus cannot tumo-
rigenic upon clinical use [3]. Therefore, the use of hAECs 
as a therapeutic approach has not challenged with the 
two major cell therapy issues, immunological rejection 
and tumor formation after transplantation.
TGF-β, IL-10, and PGE2 are known as powerful immu-
nosuppressive molecules that play a pivotal role in reg-
ulation of the immune system [6, 15–19]. These factors 
impair the proliferation and differentiation of immune 
cells and inhibit the production of pro-inflammatory 
cytokines [4, 15, 19]. Several studies indicated that 
hAECs suppressed immune cells proliferation through 
TGF-β1 and PGE2 [3, 4]. Regarding the fact that hAECs 
express different TLRs and engagement of TLRs by 
PAMP influences hAECs function, the critical question 
was whether TLR-4 stimulation by LPS, as an important 
TLR for hAECs, affects the production of immunosup-
pressive and immunostimulatory mediators of hAECs.
In the current study, we observed that LPS had the 
ability to induce the expression of TGF-β1 and PGE2 
synthase in hAECs but not for IL-10. For the first time, 
these results showed that the stimulation of hAECs with 
LPS may be considered as an approach for enhancing 
the immunoregulatory effects of these cells. However, 
the molecular mechanism involved in LPS effects on up-
regulation of immunosuppressive molecules in hAECs 
is unknown. Therefore, this is a question that must be 
addressed in future studies. As mentioned before, no sta-
tistically significant increase of IL-10 level was observed 
in the LPS-treated hAECs. This finding may be explained 
in the context of very low expression of IL-10 in these 
cells, as some reports have shown that hAECs are unable 
to produce IL-10 [4, 14].
This study unexpectedly indicated that LPS did not 
affect the level of IL-1β and IL-6 in the hAECs. These 
results were in contrast with the known mechanism of 
TLR4 function, leading to activation of the NF-κB path-
way and an increase in the production of pro-inflam-
matory cytokines [8]. However, there is a report that 
indicated the activation of TLR4 on hAECs by LPS influ-
enced the viability of the cells, while cannot affect the 
production of pro-inflammatory cytokines by these cells 
[7]. In addition, it has been demonstrated that hAECs 
activation by TLR6/2, TLR 5 and TLR9 agonists produces 
IL-6 and IL-8, but not with LPS [7, 20]. In an effort to dis-
cover the effects of LPS on TNF-α expression, we found 
that there was an inconsistency in the expression of 
TNF-α in hAECs. In contrast with some studies indicat-
ing TNF-α expression by hAECs [5, 6], the results of this 
study demonstrated that the expression level of IFN-γ 
le was below the detection limit in hAECs, and the level 
was unchanged after stimulation with LPS. The IFN-γ 
level was only detectable in some of hAECs samples.
Taken together, the results of this study provide 
evidence to show that LPS may enhance the immu-
nomodulatory effects of hAECs through up-regulat-
ing immunosuppressive factors and down-regulating 
pro-inflammatory cytokines in hAECs that may repre-
sent an advantageous cell source with potential appli-
cations for regenerative medicine. However, further 
studies are required to confirm the effects of LPS on 
Fig. 3 The expression level of pro-inflammatory cytokines in hAECs. 
hAECs were cultured in the presence or absence of LPS for 6 h. LPS 
effects on the expression of IL-1β and IL-6 cytokines in hAECs were 
evaluated by real-time PCR assay. Data are representative of ten 
independent experiments. All data show mean ± SE. NS indicates that 
the difference in the expression levels is not statistically significant
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immunomodulatory effects of hAECs and also explain 
the molecular mechanisms of LPS effects on hAECs.
Limitation
The study was unable to determine whether LPS also 
affects the production of immunomodulatory and immu-
nostimulatory factors of hAECs.
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